Regulatory Pressures And Cost Hikes Will Squeeze Hygiene Margins

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
20 Jul 25
Updated
20 Jul 25
AnalystLowTarget's Fair Value
SEK 230.00
6.4% overvalued intrinsic discount
20 Jul
SEK 244.70
Loading
1Y
-18.8%
7D
1.3%

Author's Valuation

SEK 230.0

6.4% overvalued intrinsic discount

AnalystLowTarget Fair Value

Key Takeaways

  • Rising regulations and sustainability trends are set to hinder Essity's traditional product demand and increase compliance and operational costs.
  • Intensifying competition and consumer shifts toward reusables threaten Essity's pricing power and revenue growth across key markets.
  • Strong pricing power, innovation, and cost-saving initiatives underpin Essity's revenue growth, margin resilience, and competitive positioning amid market volatility and evolving consumer demand.

Catalysts

About Essity
    Develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Growing environmental regulations and the accelerating pushback against single-use plastics are set to constrain demand for disposable hygiene products, increasing compliance costs, and potentially reducing core revenue streams for Essity over the long term.
  • The demographic trend of aging populations in developed markets could shift demand away from traditional incontinence and tissue products toward alternatives such as reusables or advanced medical solutions, which threatens sustained sales momentum in Essity's key segments.
  • Prolonged difficulties in fully passing increased raw material, energy, and distribution costs onto consumers, combined with ongoing cost inflation, are likely to continue compressing Essity's gross and net margins, even as competition intensifies.
  • Expansion of private label and low-cost competitors, particularly in Europe and North America, is expected to erode volume growth and force further price competition, undermining Essity's branded revenue and profitability over time.
  • Sector-wide substitution toward reusable and more sustainable alternatives in baby, feminine, and tissue products is likely to erode category volumes and pricing power for Essity, resulting in long-term revenue and earnings headwinds.

Essity Earnings and Revenue Growth

Essity Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • This narrative explores a more pessimistic perspective on Essity compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
  • The bearish analysts are assuming Essity's revenue will decrease by 0.6% annually over the next 3 years.
  • The bearish analysts assume that profit margins will increase from 8.6% today to 8.9% in 3 years time.
  • The bearish analysts expect earnings to reach SEK 13.3 billion (and earnings per share of SEK 19.51) by about July 2028, up from SEK 12.5 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 13.2x on those 2028 earnings, down from 13.6x today. This future PE is lower than the current PE for the GB Household Products industry at 15.3x.
  • Analysts expect the number of shares outstanding to decline by 1.37% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 4.91%, as per the Simply Wall St company report.

Essity Future Earnings Per Share Growth

Essity Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Persistent pricing power and successful price management across multiple segments-even in the face of raw material and tariff cost increases-have allowed Essity to fully offset margin headwinds, supporting resilient gross profit and protecting net earnings.
  • Sustained growth and market share gains in strategic categories such as Feminine Care, Incontinence Care Retail, and Wound Care across diverse geographies are driving higher-value sales, underpinning revenue strength and margin expansion over time.
  • Ongoing innovation, brand investment, and tiered product strategies enable Essity to tap into both premium and value segments, preserving competitiveness and protecting volume and revenue growth even as consumer price-sensitivity fluctuates.
  • Targeted, ongoing cost-saving initiatives in both COGS and SG&A, combined with efficiency improvements in supply chain and digitalization, position Essity to mitigate cost inflation and enhance profit margins in future periods.
  • Recognition for sustainability leadership and impactful brand campaigns enhances long-term brand equity, supports premium pricing, and could drive customer loyalty, all of which may contribute positively to both revenue and profit growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bearish price target for Essity is SEK230.0, which represents the lowest price target estimate amongst analysts. This valuation is based on what can be assumed as the expectations of Essity's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of SEK345.0, and the most bearish reporting a price target of just SEK230.0.
  • In order for you to agree with the bearish analysts, you'd need to believe that by 2028, revenues will be SEK148.1 billion, earnings will come to SEK13.3 billion, and it would be trading on a PE ratio of 13.2x, assuming you use a discount rate of 4.9%.
  • Given the current share price of SEK245.6, the bearish analyst price target of SEK230.0 is 6.8% lower. Despite analysts expecting the underlying buisness to improve, they seem to believe the market's expectations are too high.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives